Subcutaneous implantable cardioverter-defibrillator implantation position predicts successful defibrillation in obese and non-obese patients-Reference-Cited by-同舟云学术

Subcutaneous implantable cardioverter-defibrillator implantation position predicts successful defibrillation in obese and non-obese patients

Published:2023-01-03 Issue: Volume: Page:
ISSN:1572-8595
Container-title:Journal of Interventional Cardiac Electrophysiology
language:en
Short-container-title:J Interv Card Electrophysiol

Author:

Hoster Clay^ORCID,Rahman Annas,Goyal Ansh,Peigh Graham,Trohman Richard,Knight Bradley P.,Huang Henry,Krishnan Kousik,Larsen Timothy,Mazur Alexander,Sharma Parikshit,Engelstein Erica,Verma Nishant,Wasserlauf Jeremiah

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10840-022-01462-z.pdf

Reference8 articles.

1. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15(10):e190–252. https://doi.org/10.1016/j.hrthm.2017.10.035.

2. Boersma L, Barr C, Knops R, et al. Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol. 2017;70(7):830–41. https://doi.org/10.1016/j.jacc.2017.06.040. (PMID: 28797351).

3. Karimianpour A, John L, Gold MR. The subcutaneous ICD: a review of the UNTOUCHED and PRAETORIAN trials. Arrhythm Electrophysiol Rev. 2021;10(2):108–12. https://doi.org/10.15420/aer.2020.47.

4. Frankel DS, Burke MC, Callans DJ, Stivland TM, Duffy E, Epstein AE. Impact of body mass index on safety and efficacy of the subcutaneous implantable cardioverter-defibrillator. JACC Clin Electrophysiol. 2018;4(5):652–9. https://doi.org/10.1016/j.jacep.2017.11.019. Epub 2018 Feb 2 PMID: 29798794.

5. Quast ABE, Baalman SWE, Brouwer TF, et al. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: the PRAETORIAN score. Heart Rhythm. 2019;16(3):403–10. https://doi.org/10.1016/j.hrthm.2018.09.029. (Epub 2018 Oct 4 PMID: 30292861).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decision‐making regarding subcutaneous implantable cardioverter defibrillator as primary prevention in patients with low ejection fraction;Pacing and Clinical Electrophysiology;2024-08-19

2. Feasibility and efficacy of extravascular implantable cardioverter-defibrillators in two patients with class III obesity;HeartRhythm Case Reports;2024-08

3. Validation of the PRAETORIAN score in a large subcutaneous implantable cardioverter-defibrillator collective: Usefulness in clinical routine;Heart Rhythm;2024-07

4. Efficacy and safety of the subcutaneous implantable cardioverter-defibrillator in patients with and without obesity: A meta-analysis;Heart Rhythm;2024-07

5. S-ICD Implantation "Tips and Tricks";Reviews in Cardiovascular Medicine;2023-07-10